Forte Biosciences (FBRX) EPS (Basic) (2016 - 2026)
Forte Biosciences' (FBRX) quarterly EPS (Basic) came in at -$1.24 in Q1 2026, up 9.64% year-on-year from -$1.13 in Q1 2025, and up 25.8% on a QoQ basis from -$1.67 in Q4 2025.
Forte Biosciences (FBRX) EPS (Basic) (2016 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 11 years of EPS (Basic) data on file, last reported at -$1.24 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 9.64% year-over-year to -$1.24 in Q1 2026; TTM through Mar 2026 was -$6.01, a 53.56% decrease from a year earlier, with the FY2025 full-year figure at -$5.0, down 606.3% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.24, up from -$1.67 in the prior quarter.
- Over the last five years, EPS (Basic) for FBRX reached as high as -$1.24 in Q1 2026 and fell as low as -$10.83 in Q2 2023.
- Historically, EPS (Basic) has averaged -$4.7 across 5 years, with a median of -$4.69 in 2024.
- On a YoY basis, EPS (Basic) climbed as much as 89.68% in 2022 and fell as far as 8590.11% in 2022.
- Year by year, EPS (Basic) stood at -$7.2 in 2022, then climbed by 29.46% to -$5.08 in 2023, then surged by 49.79% to -$2.55 in 2024, then soared by 34.38% to -$1.67 in 2025, then increased by 25.8% to -$1.24 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.24 in Q1 2026, -$1.67 in Q4 2025, and -$2.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Forte Biosciences | 994.79 Mn | 936.59 Mn | - | -1.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.24 |
| Dec 31, 2025 | -1.67 |
| Sep 30, 2025 | -2.01 |
| Jun 30, 2025 | -2.10 |
| Mar 31, 2025 | -1.37 |
| Dec 31, 2024 | -2.55 |
| Sep 30, 2024 | -4.69 |
| Jun 30, 2024 | -6.96 |
| Mar 31, 2024 | -4.25 |
| Dec 31, 2023 | -5.08 |
| Sep 30, 2023 | -6.75 |
| Jun 30, 2023 | -10.83 |
| Mar 31, 2023 | -8.24 |
| Dec 31, 2022 | -7.20 |
| Sep 30, 2022 | -4.65 |
| Jun 30, 2022 | -5.48 |
| Mar 31, 2022 | -4.77 |
| Dec 31, 2021 | -23.06 |
| Sep 30, 2021 | -15.33 |
| Jun 30, 2021 | -53.15 |